New insights into the molecular mechanism of interleukin-10-mediated immunosuppression

Journal of Leukocyte Biology

Volumn 77, Issue 1, 2005, Pages 3-15

  Grütz, Gerald ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Endotoxin tolerance; Gene expression profiling; IL 10; Regulatory T cells

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; ENDOTOXIN; HEME OXYGENASE 1; INTERLEUKIN 10; PROTEIN; PROTEIN B ATF; PROTEIN BCL 3; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR C MAF; UNCLASSIFIED DRUG; LIPOPOLYSACCHARIDE;

ANTIGEN PRESENTATION; ANTIINFLAMMATORY ACTIVITY; BONE MARROW CELL; COLITIS; DESENSITIZATION; DRUG MECHANISM; DRUG TARGETING; GENE EXPRESSION PROFILING; HUMAN; IMMUNOMODULATION; LYMPHOCYTE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; PUBLICATION; REVIEW; SHOCK; SIGNAL TRANSDUCTION; T LYMPHOCYTE; ANIMAL; IMMUNOSUPPRESSIVE TREATMENT;

ANIMALS; ENDOTOXINS; HUMANS; IMMUNOSUPPRESSION; INTERLEUKIN-10; LIPOPOLYSACCHARIDES;

EID: 14644414825     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0904484     Document Type: Review

References (171)

1. Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K., Muller, W. (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263-274.
2. Berg, D. J., Kuhn, R., Rajewsky, K., Muller, W., Menon, S., Davidson, N., Grunig, G., Rennick, D. (1995) Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J. Clin. Invest. 96, 2339-2347.
3. Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D. (1992) Targeted disruption of the mouse transforming growth factor-β 1 gene results in multifocal inflammatory disease. Nature 359, 693-699.
4. Volk, H. D., Reinke, P., Docke, W. D. (2000) Clinical aspects: from systemic inflammation to 'immunoparalysis'. Chem. Immunol. 74, 162-177.
5. Schroder, M., Meisel, C., Buhl, K., Profanter, N., Sievert, N., Volk, H. D., Grutz, G. (2003) Different Modes of IL-10 and TGF-β to inhibit cytokine-dependent IFN-γ production: consequences for reversal of lipopolysaccharide desensitization. J. Immunol. 170, 5260-5267.
6. Sakaguchi, S. (2004) Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22, 531-562.
7. Blaser, K., Akdis, C. A. (2004) Interleukin-10, T regulatory cells and specific allergy treatment. Clin. Exp. Allergy 34, 328-331.
8. McFadden, G., Murphy, P. M. (2000) Host-related immunomodulators encoded by poxviruses and herpesviruses. Curr. Opin. Microbiol. 3, 371-378.
9. Haig, D. M., McInnes, C. J. (2002) Immunity and counter-immunity during infection with the parapoxvirus orf virus. Virus Res. 88, 3-16.
10. Asadullah, K., Sterry, W., Volk, H. D. (2003) Interleukin-10 therapy-review of a new approach. Pharmacol. Rev. 55, 241-269.
11. Fiorentino, D. F., Bond, M. W., Mosmann, T. R. (1989) Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170, 2081-2095.
12. Del Prete, G., De Carli, M., Almerigogna, F., Giudizi, M. G., Biagiotti, R., Romagnani, S. (1993) Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol. 150, 353-360.
13. de Waal Malefyt, R., Haanen, J., Spits, H., Roncarolo, M. G., te Velde, A., Figdor, C., Johnson, K., Kastelein, R., Yssel, H., de Vries, J. E. (1991) Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174, 915-924.
14. Fiorentino, D. F., Zlotnik, A., Vieira, P., Mosmann, T. R., Howard, M., Moore, K. W., O'Garra, A. (1991) IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146, 3444-3451.
15. de Waal Malefyt, R., Yssel, H., de Vries, J. E. (1993) Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J. Immunol. 150, 4754-4765.
16. Akdis, C. A., Joss, A., Akdis, M., Faith, A., Blaser, K. (2000) A molecular basis for T cell suppression by IL-10: CD28-associatecl IL-10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol 3-kinase binding. FASEB J. 14, 1666-1668.
17. Thompson-Snipes, L., Dhar, V., Bond, M. W., Mosmann, T. R., Moore, K. W., Rennick, D. M. (1991) Interleukin 10: a novel stimulatory factor for mast cells and their progenitors. J. Exp. Med. 173, 507-510.
18. MacNeil, I. A., Suda, T., Moore, K. W., Mosmann, T. R., Zlotnik, A. (1990) IL-10, a novel growth cofactor for mature and immature T cells. J. Immunol. 145, 4167-4173.
19. Arock, M., Zuany-Amorim, C., Singer, M., Benhamou, M., Pretolani, M. (1996) Interleukin-10 inhibits cytokine generation from mast cells. Eur. J. Immunol. 26, 166-170.
20. Marshall, J. S., Leal-Berumen, I., Nielsen, L., Glibetic, M., Jordana, M. (1996) Interleukin (IL)-10 inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells. J. Clin. Invest. 97, 1122-1128.
21. Go, N. F., Castle, B. E., Barrett, R., Kastelein, R., Dang, W., Mosmann, T. R., Moore, K. W., Howard, M. (1990) Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells. J. Exp. Med. 172, 1625-1631.
22. Defrance, T., Vanbervliet, B., Briere, F., Durand, I., Rousset, F., Banchereau, J. (1992) Interleukin 10 and transforming growth factor β cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J. Exp. Med. 175, 671-682.
23. Rousset, F., Garcia, E., Defrance, T., Peronne, C., Vezzio, N., Hsu, D. H., Kastelein, R., Moore, K. W., Banchereau, J. (1992) Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci. USA 89, 1890-1893.
24. Punnonen, J., de Waal Malefyt, R., van Vlasselaer, P., Gauchat, J. F., de Vries, J. E. (1993) IL-10 and viral IL-10 prevent IL-4-induced IgE synthesis by inhibiting the accessory cell function of monocytes. J. Immunol. 151, 1280-1289.
25. D'Andrea, A., Aste-Amezaga, M., Valiante, N. M., Ma, X., Kubin, M., Trinchieri, G. (1993) Interleukin 10 (IL-10) inhibits human lymphocyte interferon γ-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178, 1041-1048.
26. Shibata, Y., Foster, L. A., Kurimoto, M., Okamura, H., Nakamura, R. M., Kawajiri, K., Justice, J. P., Van Scott, M. R., Myrvik, Q. N., Metzger, W. J. (1998) Immunoregulatory roles of IL-10 in innate immunity: IL-10 inhibits macrophage production of IFN-γ-inducing factors but enhances NK cell production of IFN-γ. J. Immunol. 161, 4283-4288.
27. Cai, G., Kastelein, R. A., Hunter, C. A. (1999) IL-10 enhances NK cell proliferation, cytotoxicity and production of IFN-γ when combined with IL-18. Eur. J. Immunol. 29, 2658-2665.
28. Bogdan, C., Vodovotz, Y., Nathan, C. (1991) Macrophage deactivation by interleukin 10. J. Exp. Med. 174, 1549-1555.
29. de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., de Vries, J. E. (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174, 1209-1220.
30. Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., O'Garra, A. (1991) IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147, 3815-3822.
31. Moore, K. W., de Waal Malefyt, R., Coffman, R. L., O'Garra, A. (2001) Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19, 683-765.
32. Jenkins, J. K., Malyak, M., Arend, W. P. (1994) The effects of interleukin-10 on interleukin-1 receptor antagonist and interleukin-1 β production in human monocytes and neutrophils. Lymphokine Cytokine Res. 13, 47-54.
33. Capsoni, F., Minonzio, F., Ongari, A. M., Carbonelli, V., Galli, A., Zanussi, C. (1995) IL-10 up-regulates human monocyte phagocytosis in the presence of IL-4 and IFN-γ. J. Leukoc. Biol. 58, 351-358.
34. Spittler, A., Schiller, C., Willheim, M., Tempfer, C., Winkler, S., Boltz-Nitulescu, G. (1995) IL-10 augments CD23 expression on U937 cells and down-regulates IL-4-driven CD23 expression on cultured human blood monocytes: effects of IL-10 and other cytokines on cell phenotype and phagocytosis. Immunology 85, 311-317.
35. Koppelman, B., Neefjes, J. J., de Vries, J. E., de Waal Malefyt, R. (1997) Interleukin-10 down-regulates MHC class II αβ peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling. Immunity 7, 861-871.
36. Willems, F., Marchant, A., Delville, J. P., Gerard, C., Delvaux, A., Velu, T., de Boer, M., Goldman, M. (1994) Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur. J. Immunol. 24, 1007-1009.
37. Allavena, P., Piemonti, L., Longoni, D., Bernasconi, S., Stoppacciaro, A., Ruco, L., Mantovani, A. (1997) IL-10 prevents the generation of dendritic cells from CD14+ blood monocytes, promotes the differentiation to mature macrophages and stimulates endocytosis of FITC-dextran. Adv. Exp. Med. Biol. 417, 323-327.
38. Buelens, C., Verhasselt, V., De Groote, D., Thielemans, K., Goldman, M., Willems, F. (1997) Interleukin-10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin-4 and granulocyte/macrophage-colony-stimulating factor. Eur. J. Immunol. 27, 756-762.
39. De Smedt, T., Van Mechelen, M., De Becker, G., Urbain, J., Leo, O., Moser, M. (1997) Effect of interleukin-10 on dendritic cell maturation and function. Eur. J. Immunol. 27, 1229-1235.
40. Morel, A. S., Quaratino, S., Douek, D. C., Londei, M. (1997) Split activity of interleukin-10 on antigen capture and antigen presentation by human dendritic cells: definition of a maturative step. Eur. J. Immunol. 27, 26-34.
41. Allavena, P., Piemonti, L., Longoni, D., Bernasconi, S., Stoppacciaro, A., Ruco, L., Mantovani, A. (1998) IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages. Eur. J. Immunol. 28, 359-369.
42. Corinti, S., Albanesi, C., la Sala, A., Pastore, S., Girolomoni, G. (2001) Regulatory activity of autocrine IL-10 on dendritic cell functions. J. Immunol. 166, 4312-4318.
43. Sweet, M. J., Hume, D. A. (1996) Endotoxin signal transduction in macrophages. J. Leukoc. Biol. 60, 8-26.
44. Poltorak, A., He, X., Smirnova, I., Liu, M. Y., Van Huffel, C., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., Freudenberg, M., Ricciardi-Castagnoli, P., Layton, B., Beutler, B. (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085-2088.
45. Akira, S., Takeda, K. (2004) Toll-like receptor signaling. Nat. Rev. Immunol. 4, 499-511.
46. Yamamoto, M., Yamazaki, S., Uematsu, S., Sato, S., Hemmi, H., Hoshino, K., Kaisho, T., Kuwata, H., Takeuchi, O., Takeshige, K., Saitoh, T., Yamaoka, S., Yamamoto, N., Yamamoto, S., Muta, T., Takeda, K., Akira, S. (2004) Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IκBζ. Nature 430, 218-222.
47. Jefferies, C. A., Doyle, S., Brunner, C., Dunne, A., Brint, E., Wietek, C., Walch, E., Wirth, T., O'Neill, L. A. (2003) Bruton's tyrosine kinase is a Toll/interleukin-1 receptor domain-binding protein that participates in nuclear factor κB activation by Toll-like receptor 4. J. Biol. Chem. 278, 26258-26264.
48. Horwood, N. J., Mahon, T., McDaid, J. P., Campbell, J., Mano, H., Brennan, F. M., Webster, D., Foxwell, B. M. (2003) Bruton's tyrosine kinase is required for lipopolysaccharide-induced tumor necrosis factor α production. J. Exp. Med. 197, 1603-1611.
49. Fukao, T., Koyasu, S. (2003) PI3K and negative regulation of TLR signaling. Trends Immunol. 24, 358-363.
50. Anderson, P., Phillips, K., Stoecklin, G., Kedersha, N. (2004) Posttranscriptional regulation of proinflammatory proteins. J. Leukoc. Biol. 76, 42-47.
51. Chen, C. Y., Shyu, A. B. (1995) AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem. Sci. 20, 465-470.
52. Manthey, C. L., Wang, S. W., Kinney, S. D., Yao, Z. (1998) SB202190, a selective inhibitor of p38 mitogen-activated protein kinase, is a powerful regulator of LPS-induced mRNAs in monocytes. J. Leukoc. Biol. 64, 409-417.
53. Dean, J. L., Brook, M., Clark, A. R., Saklatvala, J. (1999) p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. J. Biol. Chem. 274, 264-269.
54. Kotlyarov, A., Neininger, A., Schubert, C., Eckert, R., Birchmeier, C., Volk, H. D., Gaestel, M. (1999) MAPKAP kinase 2 is essential for LPS-induced TNF-α biosynthesis. Nat. Cell Biol. 1, 94-97.
55. Kontoyiannis, D., Pasparakis, M., Pizarro, T. T., Cominelli, F., Kollias, G. (1999) Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 10, 387-398.
56. Dean, J. L., Sully, G., Clark, A. R., Saklatvala, J. (2004) The involvement of AU-rich element-binding proteins in p38 mitogen-activated protein kinase pathway-mediated mRNA stabilization. Cell. Signal. 16, 1113-1121.
57. Blackshear, P. J. (2002) Tristetraprolin and other CCCH tandem zinc-finger proteins in the regulation of mRNA turnover. Biochem. Soc. Trans. 30, 945-952.
58. Taylor, G. A., Carballo, E., Lee, D. M., Lai, W. S., Thompson, M. J., Patel, D. D., Schenkman, D. I., Gilkeson, G. S., Broxmeyer, H. E., Haynes, B. F., Blackshear, P. J. (1996) A pathogenetic role for TNF α in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 4, 445-454.
59. Black, R. A. (2002) Tumor necrosis factor-α converting enzyme. Int. J. Biochem. Cell Biol. 34, 1-5.
60. Martinen, F., Tschopp, J. (2004) Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 117, 561-574.
61. Perregaux, D., Gabel, C. A. (1994) Interleukin-1 β maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. J. Biol. Chem. 269, 15195-15203.
62. Labasi, J. M., Petrushova, N., Donovan, C., McCurdy, S., Lira, P., Payette, M. M., Brissette, W., Wicks, J. R., Audoly, L., Gabel, C. A. (2002) Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response. J. Immunol. 168, 6436-6445.
63. Randow, F., Syrbe, U., Meisel, C., Krausch, D., Zuckermann, H., Platzer, C., Volk, H. D. (1995) Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor β. J. Exp. Med. 181, 1887-1892.
64. Howard, M., Muchamuel, T., Andrade, S., Menon, S. (1993) Interleukin 10 protects mice from lethal endotoxemia. J. Exp. Med. 177, 1205-1208.
65. Ziegler-Heitbrock, H. W., Wedel, A., Schraut, W., Strobel, M., Wendelgass, P., Sternsdorf, T., Bauerle, P. A., Haas, J. G., Riethmuller, G. (1994) Tolerance to lipopolysaccharide involves mobilization of nuclear factor κ B with predominance of p50 homodimers. J. Biol. Chem. 269, 17001-17004.
66. Bohuslav, J., Kravchenko, V. V., Parry, G. C., Erlich, J. H., Gerondakis, S., Mackman, N., Ulevitch, R. J. (1998) Regulation of an essential innate immune response by the p50 subunit of NF-κB. J. Clin. Invest. 102, 1645-1652.
67. Medvedev, A. E., Kopydlowski, K. M., Vogel, S. N. (2000) Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of cytokine, chemokine, and Toll-like receptor 2 and 4 gene expression. J. Immunol. 164, 5564-5574.
68. Nomura, F., Akashi, S., Sakao, Y., Sato, S., Kawai, T., Matsumoto, M., Nakanishi, K., Kimoto, M., Miyake, K., Takeda, K., Akira, S. (2000) Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface Toll-like receptor 4 expression. J. Immunol. 164, 3476-3479.
69. Medvedev, A. E., Henneke, P., Schromm, A., Lien, E., Ingalls, R., Fenton, M. J., Golenbock, D. T., Vogel, S. N. (2001) Induction of tolerance to lipopolysaccharide and mycobacterial components in Chinese hamster ovary/CD14 cells is not affected by overexpression of Toll-like receptors 2 or 4. J. Immunol. 167, 2257-2267.
70. Medvedev, A. E., Vogel, S. N. (2003) Overexpression of CD14, TLR4, and MD-2 in HEK 293T cells does not prevent induction of in vitro endotoxin tolerance. J. Endotoxin Res. 9, 60-64.
71. Zhang, Y., Blattman, J. N., Kennedy, N. J., Duong, J., Nguyen, T., Wang, Y., Davis, R. J., Greenberg, P. D., Flavell, R. A., Dong, C. (2004) Regulation of innate and adaptive immune responses by MAP kinase phosphatase 5. Nature 430, 793-797.
72. Sly, L. M., Rauh, M. J., Kalesnikoff, J., Song, C. H., Krystal, G. (2004) LPS-induced upregulation of SHIP is essential for endotoxin tolerance. Immunity 21, 227-239.
73. Fang, H., Pengal, R. A., Cao, X., Ganesan, L. P., Wewers, M. D., Marsh, C. B., Tridandapani, S. (2004) Lipopolysaccharide-induced macrophage inflammatory response is regulated by SHIP. J. Immunol. 173, 360-366.
74. Starr, R., Willson, T. A., Viney, E. M., Murray, L. J., Rayner, J. R., Jenkins, B. J., Gonda, T. J., Alexander, W. S., Metcalf, D., Nicola, N. A., Hilton, D. J. (1997) A family of cytokine-inducible inhibitors of signalling. Nature 387, 917-921.
75. Nakagawa, R., Naka, T., Tsutsui, H., Fujimoto, M., Kimura, A., Abe, T., Seki, E., Sato, S., Takeuehi, O., Takeda, K., Akira, S., Yamanishi, K., Kawase, I., Nakanishi, K., Kishimoto, T. (2002) SOCS-1 participates in negative regulation of LPS responses. Immunity 17, 677-687.
76. Kinjyo, I., Hanada, T., Inagaki-Ohara, K., Mori, H., Aki, D., Ohishi, M., Yoshida, H., Kubo, M., Yoshimura, A. (2002) SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity 17, 583-591.
77. Randow, F., Docke, W. D., Bundschuh, D. S., Hartung, T., Wendel, A., Volk, H. D. (1997) In vitro prevention and reversal of lipopolysaccharide desensitization by IFN-γ, IL-12, and granulocyte-macrophage colony-stimulating factor. J. Immunol. 158, 2911-2918.
78. Docke, W. D., Randow, F., Syrbe, U., Krausch, D., Asadullah, K., Reinke, P., Volk, H. D., Kox, W. (1997) Monocyte deactivation in septic patients: restoration by IFN-γ treatment. Nat. Med. 3, 678-681.
79. Gingras, S., Parganas, E., de Pauw, A., Ihle, J. N., Murray, P. J. (2004) Re-examination of the role of SOCS1 in the regulation of Toll-like receptor signaling. J. Biol. Chem. Oct. 18 [Epub ahead of print].
80. Geng, Y., Gulbins, E., Altman, A., Lotz, M. (1994) Monocyte deactivation by interleukin 10 via inhibition of tyrosine kinase activity and the Ras signaling pathway. Proc. Natl. Acad. Sci. USA 91, 8602-8606.
81. Niiro, H., Otsuka, T., Ogami, E., Yamaoka, K., Nagano, S., Akahoshi, M., Nakashima, H., Arinobu, Y., Izuhara, K., Niho, Y. (1998) MAP kinase pathways as a route for regulatory mechanisms of IL-10 and IL-4 which inhibit COX-2 expression in human monocytes. Biochem. Biophys. Res. Commun. 250, 200-205.
82. Wang, P., Wu, P., Siegel, M. I., Egan, R. W., Billah, M. M. (1995) Interleukin (IL)-10 inhibits nuclear factor κ B (NF κ B) activation in human monocytes, IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J. Biol. Chem. 270, 9558-9563.
83. Song, S., Ling-Hu, H., Roebuck, K. A., Rabbi, M. F., Donnelly, R. P., Finnegan, A. (1997) Interleukin-10 inhibits interferon-γ-induced intercellular adhesion molecule-1 gene transcription in human monocytes. Blood 89, 4461-4469.
84. Lentsch, A. B., Shanley, T. P., Sarma, V., Ward, P. A. (1997) In vivo suppression of NF-κ B and preservation of Iκ Bα by interleukin-10 and interleukin-13. J. Clin. Invest. 100, 2443-2448.
85. Schottelius, A. J., Mayo, M. W., Sartor, R. B., Baldwin Jr., A. S. (1999) Interleukin-10 signaling blocks inhibitor of κB kinase activity and nuclear factor κB DNA binding. J. Biol. Chem. 274, 31868-31874.
86. Dokter, W. H., Koopmans, S. B., Vellenga, E. (1996) Effects of IL-10 and IL-4 on LPS-induced transcription factors (AP-1, NF-IL6 and NF-κ B), which are involved in IL-6 regulation. Leukemia 10, 1308-1316.
87. Takeshita, S., Gage, J. R., Kishimoto, T., Vredevoe, D. L., Martinez-Maza, O. (1996) Differential regulation of IL-6 gene transcription and expression by IL-4 and IL-10 in human monocytic cell lines. J. Immunol. 156, 2591-2598.
88. Clarke, C. J., Hales, A., Hunt, A., Foxwell, B. M. (1998) IL-10-mediated suppression of TNF-α: production is independent of its ability to inhibit NF κ B activity. Eur. J. Immunol. 28, 1719-1726.
89. Foey, A. D., Parry, S. L., Williams, L. M., Feldmann, M., Foxwell, B. M., Brennan, F. M. (1998) Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-α: role of the p38 and p42/44 mitogen-activated protein kinases. J. Immunol. 160, 920-928.
90. Donnelly, R. P., Dickensheets, H., Finbloom, D. S. (1999) The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes. J. Interferon Cytokine Res. 19, 563-573.
91. Denys, A., Udalova, I. A., Smith, C., Williams, L. M., Ciesielski, C. J., Campbell, J., Andrews, C., Kwaitkowski, D., Foxwell, B. M. (2002) Evidence for a dual mechanism for IL-10 suppression of TNF-α production that does not involve inhibition of p38 mitogen-activated protein kinase or NF-κ B in primary human macrophages. J. Immunol. 168, 4837-4845.
92. Berlato, C., Cassatella, M. A., Kinjyo, I., Gatto, L., Yoshimura, A., Bazzoni, F. (2002) Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation. J. Immunol. 168, 6404-6411.
93. Zhou, L., Nazarian, A. A., Smale, S. T. (2004) Interleukin-10 inhibits interleukin-12 p40 gene transcription by targeting a late event in the activation pathway. Mol. Cell. Biol. 24, 2385-2396.
94. Driessler, F., Venstrom, K., Sabat, R., Asadullah, K., Schottelius, A. J. (2004) Molecular mechanisms of interleukin-10-mediated inhibition of NF-κB activity: a role for p50. Clin. Exp. Immunol. 135, 64-73.
95. Wang, P., Wu, P., Siegel, M. I., Egan, R. W., Billah, M. M. (1994) IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J. Immunol. 153, 811-816.
96. Aste-Amezaga, M., Ma, X., Sartori, A., Trinchieri, G. (1998) Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10. J. Immunol. 160, 5936-5944.
97. Bogdan, C., Paik, J., Vodovotz, Y., Nathan, C. (1992) Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-β and interleukin-10. J. Biol. Chem. 267, 23301-23308.
98. Niiro, H., Otsuka, T., Tanabe, T., Kara, S., Kuga, S., Nemoto, Y., Tanaka, Y., Nakashima, H., Kitajima, S., Abe, M. (1995) Inhibition by interleukin-10 of inducible cyclooxygenase expression in lipopolysaccharide- stimulated monocytes: its underlying mechanism in comparison with interleukin-4. Blood 85, 3736-3745.
99. Brown, C. Y., Lagnado, C. A., Vadas, M. A., Goodall, G. J. (1996) Differential regulation of the stability of cytokine mRNAs in lipopolysaccharicle-activated blood monocytes in response to interleukin-10. J. Biol. Chem. 271, 20108-20112.
100. Kishore, R., Tebo, J. M., Kolosov, M., Hamilton, T. A. (1999) Cutting edge: clustered AU-rich elements are the target of IL-10-mediated mRNA destabilization in mouse macrophages. J. Immunol. 162, 2457-2461.
101. Kontoyiannis, D., Kotlyarov, A., Carballo, E., Alexopoulou, L., Blackshear, P. J., Gaestel, M., Davis, R., Flavell, R., Kollias, G. (2001) Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology. EMBO J. 20, 3760-3770.
102. Bhattacharyya, S., Sen, P., Wallet, M., Long, B., Baldwin Jr., A. S., Tisch, R. (2004) Immunoregulation of dendritic cells by IL-10 is mediated through suppression of the PI3K/Akt pathway and of I{κ}B kinase activity. Blood 104, 1100-1109.
103. Finbloom, D. S., Winestock, K. D. (1995) IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 α and STAT3 complexes in human T cells and monocytes. J. Immunol. 155, 1079-1090.
104. Wehinger, J., Gouilleux, F., Groner, B., Finke, J., Mertelsmann, R., Weber-Nordt, R. M. (1996) IL-10 induces DNA binding activity of three STAT proteins (Stat1, Stat3, and Stat5) and their distinct combinatorial assembly in the promoters of selected genes. FEBS Lett. 394, 365-370.
105. Novak, U., Ji, H., Kanagasundaram, V., Simpson, R., Paradiso, L. (1998) STAT3 forms stable homodimers in the presence of divalent cations prior to activation. Biochem. Biophys. Res. Commun. 247, 558-563.
106. Haan, S., Kortylewski, M., Behrmann, I., Muller-Esterl, W., Heinrich, P. C., Schaper, F. (2000) Cytoplasmic STAT proteins associate prior to activation. Biochem. J. 345, 417-421.
107. Braunstein, J., Brutsaert, S., Olson, R., Schindler, C. (2003) STATs dimerize in the absence of phosphorylation. J. Biol. Chem. 278, 34133-34140.
108. Ota, N., Brett, T. J., Murphy, T. L., Fremont, D. H., Murphy, K. M. (2004) N-domain-dependent nonphosphorylated STAT4 dimers required for cytokine-driven activation. Nat. Immunol. 5, 208-215.
109. Schroder, M., Kroeger, K. M., Volk, H. D., Eidne, K. A., Grutz, G. (2004) Preassociation of nonactivated STAT3 molecules demonstrated in living cells using bioluminescence resonance energy transfer: a new model of STAT activation? J. Leukoc. Biol. 75, 792-797.
110. Wang, M., Hu, Y., Shima, I., Stearns, M. E. (2002) IL-10/IL-10 receptor signaling regulates TIMP-I expression in primary human prostate tumor lines. Cancer Biol. Ther. 1, 556-563.
111. Pestka, S., Krause, C. D., Sarkar, D., Walter, M. R., Shi, Y., Fisher, P. B. (2004) Interleukin-10 and related cytokines and receptors. Annu. Rev. Immunol. 22, 929-979.
112. Donnelly, R. P., Sheikh, F., Kotenko, S. V., Dickensheets, H. (2004) The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain. J. Leukoc. Biol. 76, 314-321.
113. Wolk, K., Kunz, S., Asadullah, K., Sabat, R. (2002) Cutting edge: immune cells as sources and targets of the IL-10 family members? J. Immunol. 168, 5397-5402.
114. Nagalakshmi, M. L., Rascle, A., Zurawski, S., Menon, S., de Waal Malefyt, R. (2004) Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells. Int. Immunopharmacol. 4, 679-691.
115. Wolk, K., Kunz, S., Witte, E., Friedrich, M., Asadullah, K., Sabat, R. (2004) IL-22 increases the innate immunity of tissues. Immunity 21, 241-254.
116. Sheppard, P., Kindsvogel, W., Xu, W., Henderson, K., Schlutsmeyer, S., Whitmore, T. E., Kuestner, R., Garrigues, U., Birks, C., Roraback, J., Ostrander, C., Dong, D., Shin, J., Presnell, S., Fox, B., Haldeman, B., Cooper, E., Taft, D., Gilbert, T., Grant, F. J., Tackett, M., Krivan, W., McKnight, G., Clegg, C., Foster, D., Klucher, K. M. (2003) IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat. Immunol. 4, 63-68.
117. Kotenko, S. V., Gallagher, G., Baurin, V. V., Lewis-Antes, A., Shen, M., Shah, N. K., Langer, J. A., Sheikh, F., Dickensheets, H., Donnelly, R. P. (2003) IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol. 4, 69-77.
118. Crawley, J. B., Williams, L. M., Mander, T., Brennan, F. M., Foxwell, B. M. (1996) Interleukin-10 stimulation of phosphatidylinositol 3-kinase and p70 S6 kinase is required for the proliferative but not the antiinflammatory effects of the cytokine. J. Biol. Chem. 271, 16357-16362.
119. O'Farrell, A-M., Liu, Y., Moore, K. W., Mui, A. L-F. (1998) IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways. EMBO J. 17, 1006-1018.
120. Takeda, K., Clausen, B. E., Kaisho, T., Tsujimura, T., Terada, N., Forster, I., Akira, S. (1999) Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 10, 39-49.
121. Williams, L., Bradley, L., Smith, A., Foxwell, B. (2004) Signal transducer and activator of transcription 3 is the dominant mediator of the antiinflammatory effects of IL-10 in human macrophages. J. Immunol. 172, 567-576.
122. Riley, J. K., Takeda, K., Akira, S., Schreiber, R. D. (1999) Interleukin-10 receptor signaling through the JAK-STAT pathway. Requirement for two distinct receptor-derived signals for anti-inflammatory action. J. Biol. Chem. 274, 16513-16521.
123. Stumpo, R., Kauer, M., Martin, S., Kolb, H. (2003) IL-10 induces gene expression in macrophages: partial overlap with IL-5 but not with IL-4 induced genes. Cytokine 24, 46-56.
124. Nolan, K. F., Strong, V., Soler, D., Fairchild, P. J., Cobbold, S. P., Croxton, R., Gonzalo, J. A., Rubio, A., Wells, M., Waldmann, H. (2004) IL-10-conditioned dendritic cells, decommissioned for recruitment of adaptive immunity, elicit innate inflammatory gene products in response to danger signals. J. Immunol. 172, 2201-2209.
125. Williams, L., Jarai, G., Smith, A., Finan, P. (2002) IL-10 expression profiling in human monocytes. J. Leukoc. Biol. 72, 800-809.
126. Kumar, A., Steinkasserer, A., Berchtold, S. (2003) Interleukin-10 influences the expression of MRP8 and MRP14 in human dendritic cells. Int. Arch. Allergy Immunol. 132, 40-47.
127. Lang, R., Patel, D., Morris, J. J., Rutschman, R. L., Murray, P. J. (2002) Shaping gene expression in activated and resting primary macrophages by IL-10. J. Immunol. 169, 2253-2263.
128. Cao, S., Liu, J., Chesi, M., Bergsagel, P. L., Ho, I. C., Donnelly, R. P., Ma, X. (2002) Differential regulation of IL-12 and IL-10 gene expression in macrophages by the basic leucine zipper transcription factor c-Maf fibrosarcoma. J. Immunol. 169, 5715-5725.
129. Kuwata, H., Watanabe, Y., Miyoshi, H., Yamamoto, M., Kaisho, T., Takeda, K., Akira, S. (2003) IL-10-inducible Bcl-3 negatively regulates LPS-induced TNF-α production in macrophages. Blood 102, 4123-4129.
130. Jung, M., Sabat, R., Kratzschmar, J., Seidel, H., Wolk, K., Schonbein, C., Schutt, S., Friedrich, M., Docke, W. D., Asadullah, K., Volk, H. D., Grutz, G. (2004) Expression profiling of IL-10-regulated genes in human monocytes and peripheral blood mononuclear cells from psoriatic patients during IL-10 therapy. Eur. J. Immunol. 34, 481-493.
131. Perrier, P., Martinez, F. O., Locati, M., Bianchi, G., Nebuloni, M., Vago, G., Bazzoni, F., Sozzani, S., Allavena, P., Mantovani, A. (2004) Distinct transcriptional programs activated by interleukin-10 with or without lipopolysaccharide in dendritic cells: induction of the B cell-activating chemokine, CXC chemokine ligand 13. J. Immunol. 172, 7031-7042.
132. Moreno, C., Merino, J., Vazquez, B., Ramirez, N., Echeverria, A., Pastor, F., Sanchez-Ibarrola, A. (2004) Anti-inflammatory cytokines induce lipopolysaccharide tolerance in human monocytes without modifying Toll-like receptor 4 membrane expression. Scand. J. Immunol. 59, 553-558.
133. Ito, S., Ansari, P., Sakatsume, M., Dickensheets, H., Vazquez, N., Donnelly, R. P., Lamer, A. C., Finbloom, D. S. (1999) Interleukin-10 inhibits expression of both interferon α- and interferon γ-induced genes by suppressing tyrosine phosphorylation of STAT1. Blood 93, 1456-1463.
134. Cassatella, M. A., Gasperini, S., Bovolenta, C., Calzetti, F., Vollebregt, M., Scapini, P., Marchi, M., Suzuki, R., Suzuki, A., Yoshimura, A. (1999) Interleukin-10 (IL-10) selectively enhances CIS3/SOCS3 mRNA expression in human neutrophils: evidence for an IL-10-induced pathway that is independent of STAT protein activation. Blood 94, 2880-2889.
135. Ding, Y., Chen, D., Tarcsafalvi, A., Su, R., Qin, L., Bromberg, J. S. (2003) Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses. J. Immunol. 170, 1383-1391.
136. Stoiber, D., Kovarik, P., Cohney, S., Johnston, J. A., Steinlein, P., Decker, T. (1999) Lipopolysaccharide induces in macrophages the synthesis of the suppressor of cytokine signaling 3 and suppresses signal transduction in response to the activating factor IFN-γ. J. Immunol. 163, 2640-2647.
137. Lang, R., Pauleau, A. L., Parganas, E., Takahashi, Y., Mages, J., Ihle, J. N., Rutschman, R., Murray, P. J. (2003) SOCS3 regulates the plasticity of gp130 signaling. Nat. Immunol. 4, 546-550.
138. Yasukawa, H., Ohishi, M., Mori, H., Murakami, M., Chinen, T., Aki, D., Hanada, T., Takeda, K., Akira, S., Hoshijima, M., Hirano, T., Chien, K. R., Yoshimura, A. (2003) IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nat. Immunol. 4, 551-556.
139. Chesrown, S. E., Monnier, J., Visner, G., Nick, H. S. (1994) Regulation of inducible nitric oxide synthase mRNA levels by LPS, INF-γ, TGF-β, and IL-10 in murine macrophage cell lines and rat peritoneal macrophages. Biochem. Biophys. Res. Commun. 200, 126-134.
140. Ruetten, H., Thiemermann, C. (1997) Interleukin-13 is a more potent inhibitor of the expression of inducible nitric oxide synthase in smooth muscle cells than in macrophages: a comparison with interleukin-4 and interleukin-10. Shock 8, 409-414.
141. Tebo, J. M., Kim, H. S., Gao, J., Armstrong, D. A., Hamilton, T. A. (1998) Interleukin-10 suppresses IP-10 gene transcription by inhibiting the production of class I interferon. Blood 92, 4742-4749.
142. Tonks, N. K. (2003) PTP1B: from the sidelines to the front lines! FEBS Lett. 546, 140-148.
143. Marchant, A., Gueydan, C., Houzet, L., Amraoui, Z., Sels, A., Huez, G., Goldman, M., Kruys, V. (1996) Defective translation of tumor necrosis factor mRNA in lipopolysaccharide-tolerant macrophages. J. Inflamm. 46, 114-123.
144. Barber, S. A., Delore, G., McNally, R., Vogel, S. N. (1996) Stimulation of the ceramide pathway partially mimics lipopolysaccharide-induced responses in murine peritoneal macrophages. Infect. Immun. 64, 3397-3400.
145. Yoza, B. K., Wells, J. D., McCall, C. E. (1998) Interleukin-1β expression after inhibition of protein phosphatases in endotoxin-tolerant cells. Clin. Diagn. Lab. Immunol. 5, 281-287.
146. Ropert, C., Closel, M., Chaves, A. C., Gazzinelli, R. T. (2003) Inhibition of a p38/stress-activated protein kinase-2-dependent phosphatase restores function of IL-1 receptor-associate kinase-1 and reverses Toll-like receptor 2- and 4-dependent tolerance of macrophages. J. Immunol. 171, 1456-1465.
147. Cheng, A., Uetani, N., Simoncic, P. D., Chaubey, V. P., Lee-Loy, A., McGlade, C. J., Kennedy, B. P., Tremblay, M. L. (2002) Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B. Dev. Cell 2, 497-503.
148. Strassmann, G., Patil-Koota, V., Finkelman, F., Fong, M., Kambayashi, T. (1994) Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2. J. Exp. Med. 180, 2365-2370.
149. Le Moine, O., Stordeur, P., Schandene, L., Marchant, A., de Groote, D., Goldman, M., Deviere, J. (1996) Adenosine enhances IL-10 secretion by human monocytes. J. Immunol. 156, 4408-4414.
150. Otterbein, L. E., Bach, F. H., Alam, J., Soares, M., Tao Lu, H., Wysk, M., Davis, R. J., Flavell, R. A., Choi, A. M. (2000) Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat. Med. 6, 422-428.
151. Otterbein, L. E., Soares, M. P., Yamashita, K., Bach, F. H. (2003) Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol. 24, 449-455.
152. Lee, T. S., Chau, L. Y. (2002) Heme oxygenase-1 mediates the antiinflammatory effect of interleukin-10 in mice. Nat. Med. 8, 240-246.
153. Ricchetti, G. A., Williams, L. M., Foxwell, B. M. (2004) Heme oxygenase 1 expression induced by IL-10 requires STAT-3 and phosphoinositol-3 kinase and is inhibited by lipopolysaccharide. J. Leukoc. Biol. 76, 719-726.
154. Lenardo, M., Siebenlist, U. (1994) Bcl-3-mediated nuclear regulation of the NF-κ B trans-activating factor. Immunol. Today 15, 145-147.
155. Echlin, D. R., Tae, H. J., Mitin, N., Taparowsky, E. J. (2000) B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos. Oncogene 19, 1752-1763.
156. Cassatella, M. A., Meda, L., Gasperini, S., Calzetti, F., Bonora, S. (1994) Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation. J. Exp. Med. 179, 1695-1699.
157. Fanger, N. A., Cosman, D., Peterson, L., Braddy, S. C., Maliszewski, C. R., Borges, L. (1998) The MHC class I binding proteins LIR-1 and LIR-2 inhibit Fc receptor-mediated signaling in monocytes. Eur. J. Immunol. 28, 3423-3434.
158. Manavalan, J. S., Rossi, P. C., Vlad, G., Piazza, F., Yarilina, A., Cortesini, R., Mancini, D., Suciu-Foca, N. (2003) High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells. Transpl. Immunol. 11, 245-258.
159. Borges, L., Cosman, D. (2000) LIRs/ILTs/MIRs, inhibitory and stimulatory Ig-superfamily receptors expressed in myeloid and lymphoid cells. Cytokine Growth Factor Rev. 11, 209-217.
160. Chang, C. C., Ciubotariu, R., Manavalan, J. S., Yuan, J., Colovai, A. I., Piazza, F., Lederman, S., Colonna, M., Cortesini, R., Dalla-Favera, R., Suciu-Foca, N. (2002) Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat. Immunol. 3, 237-243.
161. Seewaldt, S., Alferink, J., Forster, I. (2002) Interleukin-10 is crucial for maintenance but not for developmental induction of peripheral T cell tolerance. Eur. J. Immunol. 32, 3607-3616.
162. Suciu-Foca, N., Manavalan, J. S., Cortesini, R. (2003) Generation and function of antigen-specific suppressor and regulatory T cells. Transpl. Immunol. 11, 235-244.
163. Asadullah, K., Sterry, W., Stephanek, K., Jasulaitis, D., Leupold, M., Audring, H., Volk, H. D., Docke, W. D. (1998) IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach. J. Clin. Invest. 101, 783-794.
164. Engel, P., Eck, M. J., Terhorst, C. (2003) The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease. Nat. Rev. Immunol. 3, 813-821.
165. Punnonen, J., Cocks, B. G., Carballido, J. M., Bennett, B., Peterson, D., Aversa, G., de Vries, J. E. (1997) Soluble and membrane-bound forms of signaling lymphocytic activation molecule (SLAM) induce proliferation and Ig synthesis by activated human B lymphocytes. J. Exp. Med. 185, 993-1004.
166. Cocks, B. G., Chang, C. C., Carballido, J. M., Yssel, H., de Vries, J. E., Aversa, G. (1995) A novel receptor involved in T-cell activation. Nature 376, 260-263.
167. Bleharski, J. R., Niazi, K. R., Sieling, P. A., Cheng, G., Modlin, R. L. (2001) Signaling lymphocytic activation molecule is expressed on CD40 ligand-activated dendritic cells and directly augments production of inflammatory cytokines. J. Immunol. 167, 3174-3181.
168. Latour, S., Gish, G., Helgason, C. D., Humphries, R. K., Pawson, T., Veillette, A. (2001) Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product. Nat. Immunol. 2, 681-690.
169. Wang, N., Satoskar, A., Faubion, W., Howie, D., Okamoto, S., Feske, S., Gullo, C., Clarke, K., Sosa, M. R., Sharpe, A. H., Terhorst, C. (2004) The cell surface receptor SLAM controls T cell and macrophage functions. J. Exp. Med. 199, 1255-1264.
170. Yanagi, Y., Ono, N., Tatsuo, H., Hashimoto, K., Minagawa, H. (2002) Measles virus receptor SLAM (CD150). Virology 299, 155-161.
171. Hahm, B., Arbour, N., Oldstone, M. B. (2004) Measles virus interacts with human SLAM receptor on dendritic cells to cause immunosuppression. Virology 323, 292-302.